Alpha Signal Monitor - Daily Market Briefing | April 16, 2026
Daily Market Research Report
April 16, 2026
Alpha Signal Monitor
Welcome to your daily pre-market briefing. This report provides key insights on market opportunities and analyst perspectives to help identify potential alpha signals.
Today's Coverage: - Gold ETF Outlook: Institutional perspectives on gold-backed ETFs - Stock Ratings: Latest analyst ratings and target prices for our watchlist - IPO Calendar: Upcoming initial public offerings and market debuts
Watchlist Stocks: AAPL, MSFT, GOOGL, AMZN, NVDA, META, TSLA, AVGO, TSM
This report is generated using advanced AI research capabilities with real-time market data access.
Institutional Outlook on Physical Gold Proxies (GLD, IAU, BAR) — as of April 16, 2026
Trading Idea: Buy Rationale (TL;DR): Consensus across top sell‑side and CIO desks remains bullish into late‑2026 on continued official‑sector buying, growing private‑sector diversification into bullion, and an easing global rate backdrop; most houses have raised 2026 targets to $4,800–$5,400/oz (with UBS higher), which supports long exposure via GLD/IAU/BAR.
Gold’s 2025 surge above $4,000/oz has extended into 2026 on strong central‑bank purchases, rising ETF/bar‑and‑coin demand, and private‑sector diversification; several banks explicitly cite a Fed cutting cycle and policy/geopolitical uncertainty as ongoing tailwinds. UBS CIO now projects $6,200 mid‑2026 and $5,900 end‑2026 with an “Attractive” rating, while Goldman Sachs lifted its Dec‑2026 target to $5,400 on private‑sector diversification plus official/ETF demand; JPMorgan reiterates gold as a conviction long with Q4‑2026 near $5,055. (ubs.com)
Key Drivers - Official‑sector (EM central bank) buying and growing private institutional allocations/“diversification demand.” (bloomberg.com) - Easier policy/declining real yields as rate‑cut cycles progress, boosting non‑yielding assets. (mining.com) - ETF/bar‑and‑coin inflows adding to tightness in available float. (ubs.com) - Elevated geopolitical and policy uncertainty (tariffs, Fed independence concerns, regional conflicts) sustaining a risk premium. (ubs.com) - Limited near‑term mine‑supply responsiveness versus demand shocks. (thestreet.com)
| Institution | Stance | Price View | Key Evidence | Last Update | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Bullish | Raised Dec‑2026 gold target to $5,400/oz (prior $4,900). | Drivers cited: private‑sector diversification into gold plus already‑strong central‑bank and ETF demand supporting higher equilibrium prices. | 2026-01-22 | (bloomberg.com) |
| Morgan Stanley | Bullish | Targets ~$4,800/oz by Q4‑2026; earlier mid‑2026 potential ~$4,500. | Views rally extending into 2026 on falling rates and persistent ETF/central‑bank demand; safe‑haven bid remains a support. | 2026-01-06 | (investing.com) |
| JP Morgan | Overweight/Bullish ("highest conviction long") | Forecasts ~$5,055/oz by Q4‑2026; upside scenarios if rotation into gold accelerates. | Expect sustained investor and official‑sector demand as Fed enters a cutting cycle; note that modest portfolio reallocation to gold could push prices higher. | 2025-10-24 | (mining.com) |
| Bank of America | Bullish | Lifts 2026 outlook to $5,000/oz (avg. ~ $4,400). | Macro drivers remain supportive (policy uncertainty, de‑dollarization, rate cuts); notes potential for near‑term consolidation despite constructive 2026 view. | 2025-10-13 | (tradingview.com) |
| Citigroup | Neutral/Cautious | 2026 average around $3,250/oz; trimmed near‑term (0–3m) to ~$3,800/oz in late‑2025. | Cites softer investment demand and improving growth as potential headwinds; maintains relatively conservative 2026 profile vs. peers. | 2025-10-28 | (tradingview.com) |
| UBS | Attractive (remain long) | Projects ~$6,200/oz for mid‑2026 with ~$5,900/oz by end‑2026 (upside case $7,200; downside $4,600). | Sees continued private‑sector diversification plus strong (if moderating) official purchases; highlights policy/geopolitical uncertainty and lower real rates as key supports. | 2026-03-12 | (ubs.com) |
| HSBC | Positive with wide range | Sees potential to ~$5,000 in 1H‑2026; trims 2026 average to about ~$4,587 and frames a wide $3,950–$5,050 trading range. | Notes supportive geopolitics/fiscal dynamics and investment demand but emphasizes volatility and potential for mid‑year flagging if risks ease. | 2026-01-08 | (investinglive.com) |
| Deutsche Bank | Positive | Raises 2026 average to ~$4,450/oz with a $3,950–$4,950 range. | Upgrades reflect resilient investor flows and persistent central‑bank demand but still characterizes 2026 as a range‑trade around elevated levels. | 2025-11-26 | (au.investing.com) |
Risk Considerations - Faster‑than‑expected disinflation or a hawkish policy pivot that lifts real yields and the USD, pressuring bullion and ETF holdings. (ubs.com) - A sharp slowdown in official‑sector purchases and/or Western ETF outflows reversing 2025–26 inflows. (tradingview.com) - Geopolitical de‑escalation or fiscal consolidation that compresses the risk premium HSBC highlights (broad $3,950–$5,050 2026 range). (za.investing.com) - Volatility around policy and liquidity events; Deutsche Bank still frames 2026 in a $3,950–$4,950 range despite an upgraded average. (au.investing.com)
Position GLD/IAU/BAR as core hedges and beneficiaries of the consensus up‑revised 2026 price path; buy‑on‑dips bias while monitoring rates and official‑sector flow data. For more aggressive upside (UBS path), maintain risk controls given elevated volatility and scenario dispersion.
Stock Ratings — Street targets and ratings snapshot from GS, MS, JPM, BAC, Citi, WFC (as of April 16, 2026)
Below is an organized, stock-by-stock consolidation of the latest available target prices, ratings, and note dates from the requested institutions. Where an institution has not published a recent, publicly visible target/rating for a given name, fields are left null.
AAPL - Apple Inc.
Coverage skewed Buy/Overweight across the six; most recent move was BAC raising target to $325 on Apr 14, 2026.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $330 | 2026-03-02 | Reiterated; analyst Michael Ng. 中文：高盛 维持买入。 | https://m.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-with-330-price-target-93CH-4482636?ampMode=1 |
| Morgan Stanley | Buy | $315 | 2026-03-23 | Overweight (equivalent to Buy). 中文：大摩 维持增持。 | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| JP Morgan | Buy | $325 | 2026-01-30 | Overweight (equivalent to Buy). 中文：小摩 上调目标价并维持增持。 | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Bank of America | Buy | $325 | 2026-04-14 | Raised target from $320; analyst Wamsi Mohan. 中文：美银 上调目标价并维持买入。 | https://www.marketbeat.com/instant-alerts/bank-of-america-raises-apple-nasdaqaapl-price-target-to-32500-2026-04-14/ |
| Citigroup | Buy | $315 | 2026-01-02 | Reiterated; analyst Atif Malik. 中文：花旗 维持买入。 | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
| Wells Fargo | Buy | $300 | 2025-10-31 | Overweight (equivalent to Buy); analyst Aaron Rakers. 中文：富国 维持增持。 | https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/ |
Consensus View - Rating: Buy, Target Price: $318.33 - Strong Buy/Overweight skew; mean target across the six ≈ $318.
MSFT - Microsoft Corp.
Post–Q2 FY26 cuts clustered on Jan 29, 2026; GS later reiterated Buy with $600; MS remains one of the higher targets at $650.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $600 | 2026-01-30 | Cut from $655 to $600 and maintained Buy. 中文：高盛 下调至$600并维持买入。 | https://uk.finance.yahoo.com/news/goldman-cuts-microsoft-msft-target-120033619.html |
| Morgan Stanley | Buy | $650 | 2026-01-07 | Overweight; top software pick into 2026 (Keith Weiss). 中文：大摩 维持增持，目标$650。 | https://finance.yahoo.com/news/morgan-stanley-top-software-pick-144952284.html |
| JP Morgan | Buy | $550 | 2026-01-29 | Lowered from $575; Overweight (Mark Murphy). 中文：小摩 下调目标并维持增持。 | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Bank of America | Buy | $500 | 2026-03-09 | Initiated coverage at Buy with $500 PT. 中文：美银 首评买入，目标$500。 | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Citigroup | Buy | $635 | 2026-01-29 | Lowered from $660; maintained Buy (Tyler Radke). 中文：花旗 下调至$635并维持买入。 | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
| Wells Fargo | Buy | $615 | 2026-01-29 | Overweight; trimmed from $630. 中文：富国 下调至$615并维持增持。 | https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/ |
Consensus View - Rating: Buy, Target Price: $591.67 - All six at Buy/Overweight; mean target ≈ $592.
GOOGL - Alphabet Inc.
Targets broadly moved higher around early Feb 2026 results; Citi most recently boosted to $405 (Apr 14, 2026).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $375 | 2026-01-13 | Raised from $330; analyst Eric Sheridan. 中文：高盛 上调至$375并维持买入。 | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Morgan Stanley | Buy | $330 | 2025-10-30 | Overweight; raised from $270. 中文：大摩 上调至$330并维持增持。 | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| JP Morgan | Buy | $395 | 2026-02-05 | Raised from $385; Overweight (Doug Anmuth). 中文：小摩 上调至$395并维持增持。 | https://www.investing.com/news/analyst-ratings/alphabet-stock-price-target-raised-to-395-by-jpmorgan-on-strong-growth-93CH-4490931 |
| Bank of America | Buy | $370 | 2025-12-02 | Raised from $335. 中文：美银 上调至$370并维持买入。 | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Citigroup | Buy | $405 | 2026-04-14 | Raised from $390 (Ronald Josey). 中文：花旗 上调至$405并维持买入。 | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
| Wells Fargo | Buy | $361 | 2026-03-06 | Overweight; cut from $397 amid capex digestion. 中文：富国 下调至$361并维持增持。 | https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/ |
Consensus View - Rating: Buy, Target Price: $372.67 - Consensus Buy with mean target ≈ $373 across the six.
AMZN - Amazon.com Inc.
Mixed recalibration around Feb 2026 capex guidance; subsequent boosts from Citi and WFC late March; GS most recently set $275 (Buy).
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $275 | 2026-04-13 | Lowered to $275; maintained Buy (AWS growth, 2026 capex context). 中文：高盛 下调至$275并维持买入。 | https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-amazon-stock-price-target-to-275-on-aws-growth-93CH-4611375 |
| Morgan Stanley | Buy | $300 | 2026-02-06 | Reiterated Overweight; trimmed from $315. 中文：大摩 下调至$300并维持增持。 | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| JP Morgan | Buy | $280 | 2026-03-23 | Raised from $265; Overweight (Doug Anmuth). 中文：小摩 上调至$280并维持增持。 | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Bank of America | Buy | $286 | 2026-01-21 | Lowered from $303; maintained Buy (Justin Post). 中文：美银 下调至$286并维持买入。 | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Citigroup | Buy | $285 | 2026-03-25 | Raised from $265; maintained Buy (Ronald Josey). 中文：花旗 上调至$285并维持买入。 | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
| Wells Fargo | Buy | $305 | 2026-03-30 | Raised from $304; Overweight. 中文：富国 上调至$305并维持增持。 | https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/ |
Consensus View - Rating: Buy, Target Price: $288.50 - All six Buy/Overweight; mean target ≈ $289.
NVDA - NVIDIA Corp.
Most of the street remains constructive into Blackwell/Rubin cycles; latest cluster shows GS $250, MS $260; BofA recently flagged a $300 PT in The Fly/TipRanks tape.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $250 | 2026-02-25 | Set target and maintained Buy. 中文：高盛 目标$250 买入。 | https://www.pricetargets.com/NASDAQ/NVDA/ |
| Morgan Stanley | Buy | $260 | 2026-02-23 | Reiterated Overweight; raised from $250 (Joseph Moore). 中文：大摩 上调至$260并维持增持。 | https://www.pricetargets.com/NASDAQ/NVDA/ |
| JP Morgan | Buy | $250 | 2025-11-20 | Overweight; raised from $215. 中文：小摩 上调至$250并维持增持。 | https://www.pricetargets.com/NASDAQ/NVDA/ |
| Bank of America | Buy | $300 | - | Raised from $275 per The Fly/TipRanks; latest precise date not shown. 中文：美银 目标$300（日期未公开）。 | https://www.tipranks.com/news/the-fly/nvidia-price-target-raised-to-300-from-275-at-bofa-thefly-news |
| Citigroup | Buy | $270 | 2025-11-20 | Raised from $220 (Atif Malik). 中文：花旗 上调至$270并维持买入。 | https://www.pricetargets.com/NASDAQ/NVDA/ |
| Wells Fargo | Buy | $265 | 2025-11-14 | Overweight; raised from $220 (Aaron Rakers). 中文：富国 上调至$265并维持增持。 | https://www.pricetargets.com/NASDAQ/NVDA/ |
Consensus View - Rating: Buy, Target Price: $265.83 - Buy/Overweight across the six; mean target ≈ $266.
META - Meta Platforms Inc.
Visible recent updates include GS Buy at $815 and MS Overweight at $850; other banks not recently public in our sweep.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | Buy | $815 | - | Maintained Buy; $815 target quoted in early 2026 coverage. 中文：高盛 维持买入，目标$815。 | https://za.investing.com/news/analyst-ratings/meta-stock-price-target-maintained-at-815-by-goldman-sachs-on-strong-q4-93CH-4083735 |
| Morgan Stanley | Buy | $850 | - | Overweight; raised target per tape summary. 中文：大摩 上调至$850并维持增持。 | https://www.boersly.com/up-and-downgrades |
| JP Morgan | - | - | - | No recent public target located in this pass. 中文：暂无公开更新。 | - |
| Bank of America | - | - | - | Recent chatter suggests higher targets, but a public primary reference wasn’t captured in this pass. 中文：传闻上调但暂无可公开引用来源。 | - |
| Citigroup | - | - | - | No recent public target located in this pass. 中文：暂无公开更新。 | - |
| Wells Fargo | - | - | - | No recent public target located in this pass. 中文：暂无公开更新。 | - |
Consensus View - Rating: Buy, Target Price: $832.50 - Consensus reflects available GS/MS inputs only; mean ≈ $833.
TSLA - Tesla Inc.
Ratings/targets from the requested banks were not surfaced in this initial pass.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Consensus View - Insufficient bank data captured in this sweep.
AVGO - Broadcom Inc.
No recent, publicly visible targets from the six banks captured in this initial sweep.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Consensus View - Pending additional sourcing.
TSM - Taiwan Semiconductor Manufacturing Co. (ADR)
No recent, publicly visible targets from the six banks captured in this initial sweep.
| Institution | Rating | Target Price | Last Update | Notes | Source |
|---|---|---|---|---|---|
| Goldman Sachs | - | - | - | - | - |
| Morgan Stanley | - | - | - | - | - |
| JP Morgan | - | - | - | - | - |
| Bank of America | - | - | - | - | - |
| Citigroup | - | - | - | - | - |
| Wells Fargo | - | - | - | - | - |
Consensus View - Pending additional sourcing.
Highlights
- AAPL: BAC raised PT to $325 on Apr 14, 2026; MS reiterated Overweight $315 on Mar 23, 2026; JPM to $325 on Jan 30, 2026. Sources: MarketBeat AAPL page and BAC alert.
- MSFT: GS Buy $600 (Jan 30, 2026); MS Overweight $650 (Jan 7, 2026); JPM cut to $550 (Jan 29, 2026); BAC initiated Buy $500 (Mar 9, 2026). Sources: Yahoo Finance, MarketBeat MSFT page.
- GOOGL: GS $375 (Jan 13, 2026); JPM to $395 (Feb 5, 2026); Citi to $405 (Apr 14, 2026); WFC to $361 (Mar 6, 2026). Source: MarketBeat GOOGL page; Investing.com.
- AMZN: GS $275 (Apr 13, 2026); JPM to $280 (Mar 23, 2026); Citi to $285 (Mar 25, 2026); WFC to $305 (Mar 30, 2026). Source: MarketBeat AMZN page; Investing.com.
- NVDA: GS $250 (Feb 25, 2026); MS $260 (Feb 23, 2026); BAC recently referenced $300; Citi $270; WFC $265. Source: PriceTargets.com; TipRanks/The Fly.
Note: Several bank research notes are paywalled; where banks did not publicly post accessible PDFs, reputable aggregators (MarketBeat/PriceTargets/Investing.com/Yahoo Finance) are referenced. Nulls indicate we did not find a recent, citable public target/rating for that bank-name/stock pair in this sweep. If you’d like, I can continue to fill in TSLA/AVGO/TSM and complete any missing META entries next.
IPO Calendar
Timeframe: April 16, 2026 to May 16, 2026 (US equity markets)
The next month features a mix of large-cap industrial and defense offerings alongside life sciences and an unusual dual IPO from an alternative asset manager. Notable themes: (1) large, sponsor-backed industrials are returning (e.g., Madison Air Solutions), (2) defense/aerospace exposure (Arxis, AEVEX) remains in favor, and (3) biotechs are re-opening the window (Alamar Biosciences; Kailera Therapeutics roadshow filing). As of April 13, 2026, Renaissance Capital data indicate 69 IPOs filed YTD and 36 priced, reflecting a slower but functioning calendar versus 2025. (renaissancecapital.com)
Arxis, Inc. (ARXS)
- Expected listing date: April 16, 2026 (priced April 15, 2026)
- Price range: Priced at $28.00 per share
- Shares offered: 40,500,000 Class A shares (+6,075,000 overallotment option)
- Exchange: Nasdaq Global Select Market
- Lead underwriters: Goldman Sachs & Co. LLC, Morgan Stanley, Jefferies, Citigroup, RBC Capital Markets, Baird, Guggenheim Securities, Wells Fargo Securities, William Blair, Rothschild & Co, Wolfe | Nomura Alliance, Citizens Capital Markets (co-manager)
- Business summary: Designer and manufacturer of proprietary, mission‑critical electronic and mechanical components for aerospace & defense, medical technology, and specialized industrial markets; portfolio company of Arcline Investment Management. IPO proceeds support liquidity for selling shareholders and corporate purposes. (sec.gov)
- Notes: Company announced final pricing on April 15, 2026, with trading expected to begin April 16, 2026; offering was upsized from initial launch terms. (prnewswire.com)
- Sources: Arxis pricing press release (PR Newswire), Apr 15, 2026, Nasdaq launch press release, Apr 8, 2026, Arxis S‑1 (SEC EDGAR), filed Mar 2026
Madison Air Solutions Corporation (MAIR)
- Expected listing date: April 16, 2026 (priced April 15, 2026)
- Price range: Priced at $27.00 per share
- Shares offered: 82,692,308 Class A shares (+12,403,846 overallotment option)
- Exchange: New York Stock Exchange
- Lead underwriters: Goldman Sachs & Co. LLC, Barclays, Jefferies, Wells Fargo Securities, BofA Securities, Citigroup, Baird, RBC Capital Markets, Guggenheim Securities, Santander, Wolfe | Nomura Alliance, CIBC Capital Markets, Comerica Securities (co‑manager), William Blair (co‑manager), Stifel (co‑manager), Capital One Securities (co‑manager), PNC Capital Markets (co‑manager)
- Business summary: Air quality solutions platform with brands including Nortek Air Solutions, Nortek Data Center Cooling, AprilAire, Big Ass Fans, Broan‑NuTone, and Reznor; serves data centers, semiconductor fabs, workplaces, and homes. IPO proceeds for general corporate purposes; concurrent $100 million Class B placement to an entity controlled by founder Larry Gies. (stocktitan.net)
- Notes: Company disclosed range and share count in S‑1/A (filed April 6, 2026); pricing confirmed by company press release April 15, 2026; several outlets note it is the largest US industrial IPO since 1999. (sec.gov)
- Sources: Madison Air pricing press release (PR Newswire) via Seeking Alpha/StockTitan, Apr 15, 2026, Madison Air S‑1/A (SEC EDGAR), Apr 6, 2026, Bloomberg Law coverage of pricing, Apr 15, 2026
Alamar Biosciences, Inc. (ALMR)
- Expected listing date: April 17, 2026 (expected)
- Price range: $15.00 – $17.00 per share (terms set)
- Shares offered: 9,375,000 shares (plus customary underwriter option)
- Exchange: Nasdaq Global Select Market
- Lead underwriters: J.P. Morgan, BofA Securities, TD Securities (USA) LLC, Leerink Partners LLC, Stifel, Nicolaus & Company, Incorporated
- Business summary: Developer of ultra‑sensitive proteomics instruments, assays, and software (NULISA platform and ARGO system) used for protein biomarker detection in disease research; proceeds to support commercialization and R&D. (sec.gov)
- Notes: Company set terms April 13, 2026; multiple calendars indicate an April 17, 2026 pricing/launch window, subject to market conditions. (renaissancecapital.com)
- Sources: Alamar S‑1/A (SEC EDGAR), Apr 13, 2026, Renaissance Capital news item (terms set), Apr 13, 2026, IPOX calendar entry (date indicative)
Pershing Square USA, Ltd. (closed‑end fund) (PSUS)
- Expected listing date: April 28, 2026 (target)
- Price range: Offered at $50.00 per share
- Exchange: New York Stock Exchange
- Lead underwriters: Citigroup, UBS, BofA Securities, Jefferies, Wells Fargo Securities
- Business summary: New NYSE‑listed closed‑end fund to be managed by Pershing Square Capital Management; concentrated large‑cap equity strategy with hedges. Initial PSUS buyers receive, for no additional consideration, 20 shares of Pershing Square Inc. (PS) for every 100 PSUS shares purchased. (sec.gov)
- Notes: Roadshow launched April 13, 2026; company communications and trade press indicate targeted pricing on April 28, 2026; firm disclosed $2.8B in prior commitments toward the combined transaction. (finance.yahoo.com)
- Sources: Pershing Square FWP (SEC), Mar 10, 2026, Business Wire/Yahoo Finance: launch of combined IPO, Apr 13, 2026, InvestmentNews: roadshow and timing, Apr 13, 2026
Pershing Square Inc. (PS)
- Expected listing date: April 28, 2026 (target; concurrent with PSUS)
- Exchange: New York Stock Exchange
- Lead underwriters: Citigroup, UBS, BofA Securities, Jefferies, Wells Fargo Securities
- Business summary: Asset‑light alternative asset manager (parent of Pershing Square Capital Management) to list concurrently with PSUS; intends to grow fee‑paying AUM via permanent‑capital vehicles (PSH, PSUS) while distributing PSI shares to PSUS IPO investors. (sec.gov)
- Notes: Structure is unusual: PSI shares are distributed to PSUS IPO investors for no additional consideration (20 PSI per 100 PSUS). Final terms for PSI’s standalone float, if any, remain subject to effectiveness and market conditions. (sec.gov)
- Sources: Pershing Square FWP (SEC), Mar 10, 2026, Axios coverage of filing, Mar 10, 2026
AEVEX Corp. (AVEX)
- Exchange: New York Stock Exchange (applied)
- Lead underwriters: Goldman Sachs & Co. LLC, BofA Securities, Jefferies, J.P. Morgan, RBC Capital Markets, Baird, William Blair, Raymond James, Needham & Company, Academy Securities, Capital One Securities, PNC Capital Markets LLC
- Business summary: Defense technology company focused on missionized capabilities enabling unmanned aerial systems (ISR and related defense applications); Madison Dearborn Partners remains the controlling stockholder post‑IPO. (sec.gov)
- Notes: Filed initial S‑1 on March 23, 2026; terms and schedule not yet set in the prospectus. Some calendars indicate a potential mid‑to‑late April launch, which is unconfirmed by the issuer. (sec.gov)
- Sources: AEVEX S‑1 (SEC EDGAR), Mar 23, 2026, IPOX calendar note (date indicative)
Kailera Therapeutics, Inc. (KLRA)
- Exchange: Nasdaq Global Select Market (applied)
- Lead underwriters: J.P. Morgan (lead; per press reports)
- Business summary: Phase 3 biotech developing injectable and oral GLP‑1/GIP agonists for obesity; proceeds to fund late‑stage trials and platform development. (renaissancecapital.com)
- Notes: Filed S‑1 on March 27, 2026 (amended April 13, 2026). Price range and launch date not yet disclosed in the prospectus; roadshow activity reported in mid‑April by media. (sec.gov)
- Sources: Kailera S‑1 (SEC EDGAR), Mar 27, 2026; S‑1/A, Apr 13, 2026, Reuters/SAHM Capital: roadshow and context, Apr 13, 2026, Renaissance Capital coverage of filing, Mar 27, 2026
Data reflect filings and company press releases available as of April 16, 2026. IPOs remain subject to SEC effectiveness and market conditions; dates and terms can change quickly (or deals can be postponed) with little notice. Where dates are marked “expected/target,” they come from company communications or reputable calendars and are not yet confirmed by final prospectuses.
Sources
- Stock Ratings: https://finance.yahoo.com/news/morgan-stanley-top-software-pick-144952284.html, https://m.investing.com/news/analyst-ratings/goldman-sachs-reiterates-buy-rating-on-apple-stock-with-330-price-target-93CH-4482636?ampMode=1, https://uk.finance.yahoo.com/news/goldman-cuts-microsoft-msft-target-120033619.html, https://www.boersly.com/up-and-downgrades, https://www.investing.com/news/analyst-ratings/alphabet-stock-price-target-raised-to-395-by-jpmorgan-on-strong-growth-93CH-4490931, https://www.investing.com/news/analyst-ratings/goldman-sachs-lowers-amazon-stock-price-target-to-275-on-aws-growth-93CH-4611375, https://www.marketbeat.com/instant-alerts/bank-of-america-raises-apple-nasdaqaapl-price-target-to-32500-2026-04-14/, https://www.marketbeat.com/stocks/NASDAQ/AAPL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/AMZN/forecast/, https://www.marketbeat.com/stocks/NASDAQ/GOOGL/forecast/, https://www.marketbeat.com/stocks/NASDAQ/MSFT/forecast/, https://www.pricetargets.com/NASDAQ/NVDA/, https://www.tipranks.com/news/the-fly/nvidia-price-target-raised-to-300-from-275-at-bofa-thefly-news, https://za.investing.com/news/analyst-ratings/meta-stock-price-target-maintained-at-815-by-goldman-sachs-on-strong-q4-93CH-4083735
- IPO Calendar: https://finance.yahoo.com/markets/stocks/articles/pershing-square-announces-launch-combined-111300898.html?utm_source=openai, https://www.prnewswire.com/news-releases/arcline-backed-arxis-announces-pricing-of-its-initial-public-offering-302743924.html, https://www.renaissancecapital.com/IPO-Center/News/117947/Obesity-biotech-Kailera-Therapeutics-files-for-a-%24100-million-IPO?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/118248/Protein-biomarker-detection-platform-Alamar-Biosciences-sets-terms-for-%24150?utm_source=openai, https://www.renaissancecapital.com/IPO-Center/News/118343/Airflow-products-manufacturer-Madison-Air-Solutions-prices-IPO-at-%2427-the-h?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2026053/000114036126008624/ny20040230x16_fwp.htm, https://www.sec.gov/Archives/edgar/data/2093536/000119312526122234/d81728ds1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2096300/000119312526119150/d22113ds1.htm, https://www.sec.gov/Archives/edgar/data/2096997/000119312526128952/d113532ds1.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2098430/000119312526142875/0001193125-26-142875-index.htm?utm_source=openai, https://www.sec.gov/Archives/edgar/data/2104204/000119312526151891/d39680ds1a.htm, https://www.stocktitan.net/news/MAIR/madison-air-announces-pricing-of-initial-public-2r8b7o82sxgq.html
Disclaimer
This research report is for informational purposes only and does not constitute investment advice. All information is sourced from publicly available data and should be verified independently. Past performance does not guarantee future results.
Generated on: 2026-04-16 at 11:50 UTC
Source: Alpha Signal Monitor - Automated Research System
Contact: For questions about this report, please contact your Alpha Signal Monitor administrator.
Powered by Alpha Signal Monitor | Market Intelligence Through AI